The PDK1 inhibitor dichloroacetate (DCA) has been shown to be effective in many cancer types, including colon and breast cancers and oral squamous cell carcinoma.59, 60, 61 In cancer cells, DCA switches the glucose metabolism from aerobic glycolysis to glucose oxidation. The gene discussed is PDK1; the disease is breast carcinoma.